Who owns DNLI?
Institutional ownership of Denali Therapeutics Inc. from Form 13F, Q2 2026
293 institutional managers reported holding Denali Therapeutics Inc. (DNLI) in Form 13F filings for Q2 2026, with 156,230,055 shares worth $4.0B. The largest reported holder was T. Rowe Price Investment Management, Inc. Managers that filed both quarters added a net 8,381,315 shares (+5.7%). 51 opened new positions and 27 sold out.
- Funds holding
- 293
- Value held
- $4.0B
- New / sold out
- 51 / 27
- Net shares, same filers
- +5.7%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of DNLI
Share of 13F holdings is each fund's shares as a share of the 156,230,055 DNLI shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- T. Rowe Price Investment Management, Inc. Added+$197M
- Norges Bank New+$72.7M
- Nomura Asset Management International Inc. Added+$53.9M
- BNP PARIBAS ASSET MANAGEMENT Holding S.A. Added+$27.2M
- BlackRock, Inc. Added+$25.5M
- State Street Corp Added+$20.0M
- Holocene Advisors, LP Added+$18.3M
- Price T Rowe Associates Inc Added+$17.3M
- UBS Group AG Added+$14.1M
- Citigroup Inc Added+$11.5M
Biggest sellers in Q2 2026
- Lynx1 Capital Management LP Trimmed-$48.1M
- Alyeska Investment Group, L.P. Trimmed-$44.3M
- Vestal Point Capital, LP Sold out-$34.0M
- UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Trimmed-$32.7M
- Defilade Capital Management, L.P. Trimmed-$24.9M
- ADAR1 Capital Management, LLC Trimmed-$21.7M
- Clearstead Advisors, LLC Trimmed-$19.0M
- Stempoint Capital LP Sold out-$16.4M
- Aberdeen Group plc Trimmed-$13.1M
- Marshall Wace, LLP Trimmed-$11.4M
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $603M and sold $361M; 116 added and 67 trimmed.
Questions about DNLI ownership
- Who owns DNLI stock?
- 293 institutional investment managers reported DNLI positions in their Form 13F filings for Q2 2026, holding 156,230,055 shares worth $4.0B in total. T. Rowe Price Investment Management, Inc. reported the largest position.
- Are funds buying or selling DNLI?
- In Q2 2026, 51 managers opened new DNLI positions, 116 added, 67 trimmed and 27 sold out. Managers that filed in both quarters added a net 8,381,315 shares.
- How current is this DNLI institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to DNLI by CUSIP. Options are left out. DNLI news and filings · DNLI insider trades · Top funds